Resveratrol prevents pathological but not physiological cardiac hypertrophy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol prevents pathological but not physiological cardiac hypertrophy
Authors
Keywords
Resveratrol, Cardiac hypertrophy, Molecular biology, Signal transduction, NFAT
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 93, Issue 4, Pages 413-425
Publisher
Springer Nature
Online
2014-11-15
DOI
10.1007/s00109-014-1220-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental Studies of the Molecular Pathways Regulated by Exercise and Resveratrol in Heart, Skeletal Muscle and the Vasculature
- (2014) Vernon Dolinsky et al. MOLECULES
- Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice
- (2013) Vernon W. Dolinsky et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
- (2013) Vernon W. Dolinsky et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Sulfate Metabolites Provide an Intracellular Pool for Resveratrol Generation and Induce Autophagy with Senescence
- (2013) K. R. Patel et al. Science Translational Medicine
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats
- (2012) Vernon W. Dolinsky et al. JOURNAL OF PHYSIOLOGY-LONDON
- Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats
- (2011) Vincent Chan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Continued Postnatal Administration of Resveratrol Prevents Diet-Induced Metabolic Syndrome in Rat Offspring Born Growth Restricted
- (2011) V. W. Dolinsky et al. DIABETES
- Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms
- (2011) Georgina M Ellison et al. HEART
- Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy
- (2011) Nagalingam R. Sundaresan et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
- (2011) Stéphanie Rimbaud et al. PLoS One
- Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats
- (2010) Peter Wojciechowski et al. JOURNAL OF NUTRITION
- Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats
- (2010) Hale Z. Toklu et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
- (2009) S. J. Thandapilly et al. AMERICAN JOURNAL OF HYPERTENSION
- Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
- (2009) Vernon W. Dolinsky et al. CIRCULATION
- AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
- (2009) J.-H. Um et al. DIABETES
- AMPKα2 counteracts the development of cardiac hypertrophy induced by isoproterenol
- (2008) Elham Zarrinpashneh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt
- (2008) Anita Y. M. Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started